Correlation Between Recursion Pharmaceuticals and Shattuck Labs
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Shattuck Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Shattuck Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Shattuck Labs, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Shattuck Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Shattuck Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Shattuck Labs.
Diversification Opportunities for Recursion Pharmaceuticals and Shattuck Labs
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Recursion and Shattuck is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Shattuck Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shattuck Labs and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Shattuck Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shattuck Labs has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Shattuck Labs go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Shattuck Labs
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.79 times more return on investment than Shattuck Labs. However, Recursion Pharmaceuticals is 1.26 times less risky than Shattuck Labs. It trades about -0.13 of its potential returns per unit of risk. Shattuck Labs is currently generating about -0.16 per unit of risk. If you would invest 687.00 in Recursion Pharmaceuticals on August 29, 2024 and sell it today you would lose (98.00) from holding Recursion Pharmaceuticals or give up 14.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Recursion Pharmaceuticals vs. Shattuck Labs
Performance |
Timeline |
Recursion Pharmaceuticals |
Shattuck Labs |
Recursion Pharmaceuticals and Shattuck Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Recursion Pharmaceuticals and Shattuck Labs
The main advantage of trading using opposite Recursion Pharmaceuticals and Shattuck Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Shattuck Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shattuck Labs will offset losses from the drop in Shattuck Labs' long position.Recursion Pharmaceuticals vs. Bright Minds Biosciences | Recursion Pharmaceuticals vs. HP Inc | Recursion Pharmaceuticals vs. Intel | Recursion Pharmaceuticals vs. Chevron Corp |
Shattuck Labs vs. C4 Therapeutics | Shattuck Labs vs. Eliem Therapeutics | Shattuck Labs vs. Prelude Therapeutics | Shattuck Labs vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |